A nasal omicron vaccine booster elicits potent neutralizing antibody response against emerging SARS-CoV-2 variants

SARS-CoV-2 has caused the COVID-19 pandemic since early 2020. As of January 2022, the worldwide spreading of SARS-CoV-2 leads to approximately 0.35 billion of human infections and five millions of deaths. Current vaccination is one of the effective ways to control SARS-CoV-2 transmission and reduce...

Descripción completa

Detalles Bibliográficos
Autores principales: Lam, Joy-Yan, Ng, Yau-Yee, Yuen, Chun-Kit, Wong, Wan-Man, Yuen, Kwok-Yung, Kok, Kin-Hang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Coronaviruses
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973333/
https://www.ncbi.nlm.nih.gov/pubmed/35275039
http://dx.doi.org/10.1080/22221751.2022.2053365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973333/
https://www.ncbi.nlm.nih.gov/pubmed/35275039
http://dx.doi.org/10.1080/22221751.2022.2053365

Ejemplares similares